Search results for query: *

  1. B

    Keyzilen (AM-101) Granted Fast Track Designation by the FDA

    From the press release: "Top-line results from the TACTT2 and TACTT3 trials are expected in August 2016 and in the fourth quarter of 2016, respectively." Until then, it's only speculation. As @swc5150 wrote above, there are plenty of posts in the other AM-101 threads where people speculate...
  2. B

    Keyzilen (AM-101) Granted Fast Track Designation by the FDA

    Seems like it's almost there... Press Release